Search research articles
Contact Us
Filters
Showing results (171-180 of 223) with videos related to
Page
of 23
Sort By:
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
May 1, 1996
Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation
T Parkkali, T Ruutu, M Stenvik, et al.
British Journal of Haematology
|
September 1, 1989
Characterization of neoplastic and reactive cells in T-cell lymphomas with cytogenetic, surface marker, and DNA methods
C Lindholm, K O Franssila, L Teerenhovi, et al.
Leukemia
|
January 1, 1994
Oral induction and consolidation of acute myeloid leukemia with etoposide, 6-thioguanine, and idarubicin (ETI) in elderly patients: a randomized comparison with 5-day TAD. Finnish Leukemia Group
T Ruutu, A Almqvist, H Hallman, et al.
Blood
|
May 1, 1994
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group
O Ringdén, T Ruutu, M Remberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 1994
Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem
V J Anttila, P Ruutu, S Bondestam, et al.
Lancet (London, England)
|
February 21, 1987
Graft-versus-leukaemia activity associated with cytomegalovirus antibody positive bone marrow donors in acute myeloid leukaemia
N Jacobsen, N Keiding, L Ryder, et al.
Vox Sanguinis
|
January 1, 1995
Tolerability and kinetics of a solvent-detergent-treated intravenous immunoglobulin preparation in hypogammaglobulinaemia patients
F Ebeling, M Baer, P Hormila, et al.
Transplantation Proceedings
|
June 1, 1994
A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies
O Ringdén, T Ruutu, M Remberger, et al.
Bone Marrow Transplantation
|
November 16, 2004
Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT)
T Ruutu, P Corradini, A Gratwohl, et al.
European Journal of Haematology
|
April 1, 1987
Graft-versus-leukaemia activity associated with cytomegalovirus seropositive bone marrow donors but separated from graft-versus-host disease in allograft recipients with AML
N Jacobsen, B Lönnqvist, O Ringdén, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 223) with videos related to
Sort By:
Page
of 23
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
|
May 1, 1996
Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation
T Parkkali, T Ruutu, M Stenvik, et al.
British Journal of Haematology
|
September 1, 1989
Characterization of neoplastic and reactive cells in T-cell lymphomas with cytogenetic, surface marker, and DNA methods
C Lindholm, K O Franssila, L Teerenhovi, et al.
Leukemia
|
January 1, 1994
Oral induction and consolidation of acute myeloid leukemia with etoposide, 6-thioguanine, and idarubicin (ETI) in elderly patients: a randomized comparison with 5-day TAD. Finnish Leukemia Group
T Ruutu, A Almqvist, H Hallman, et al.
Blood
|
May 1, 1994
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group
O Ringdén, T Ruutu, M Remberger, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 1, 1994
Hepatosplenic yeast infection in patients with acute leukemia: a diagnostic problem
V J Anttila, P Ruutu, S Bondestam, et al.
Lancet (London, England)
|
February 21, 1987
Graft-versus-leukaemia activity associated with cytomegalovirus antibody positive bone marrow donors in acute myeloid leukaemia
N Jacobsen, N Keiding, L Ryder, et al.
Vox Sanguinis
|
January 1, 1995
Tolerability and kinetics of a solvent-detergent-treated intravenous immunoglobulin preparation in hypogammaglobulinaemia patients
F Ebeling, M Baer, P Hormila, et al.
Transplantation Proceedings
|
June 1, 1994
A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies
O Ringdén, T Ruutu, M Remberger, et al.
Bone Marrow Transplantation
|
November 16, 2004
Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT)
T Ruutu, P Corradini, A Gratwohl, et al.
European Journal of Haematology
|
April 1, 1987
Graft-versus-leukaemia activity associated with cytomegalovirus seropositive bone marrow donors but separated from graft-versus-host disease in allograft recipients with AML
N Jacobsen, B Lönnqvist, O Ringdén, et al.
Page
of 23